| Literature DB >> 29359845 |
Allison Kutner1, Margaret Aldrich2, Sarju Patel3, Joann J Kang4, Bijal Amin5, Ranon Mann1, Ibne Karim M Ali6, Roosecelis Brasil Martines7, Jennifer Rittenhouse Cope6, Graciela O De Boccardo8, Yoram A Puius2.
Abstract
Acanthamoeba infections are difficult to diagnose and treat. We present a renal transplant patient who developed Acanthamoeba endophthalmitis on therapy with posaconazole and miltefosine for cutaneous acanthamobiasis. The patient was maintained on intracameral voriconazole injections, and oral azithromycin, fluconazole, and flucytosine. This case highlights novel presentations and treatments for acanthamoebic infection.Entities:
Keywords: zzm321990Acanthamoebazzm321990; amoebiasis; endophthalmitis; miltefosine; posaconazole
Mesh:
Substances:
Year: 2018 PMID: 29359845 PMCID: PMC5973505 DOI: 10.1111/tid.12843
Source DB: PubMed Journal: Transpl Infect Dis ISSN: 1398-2273 Impact factor: 2.228